The Effects of Taking Weight-Loss Drugs
In breaking news, Pfizer decided to halt the development of the twice-daily version of its experimental weight-loss pill due to serious side effects.
Personality, Behavior, and the New Weight-loss Drugs, Part 3
Some people carry on eating after they’re full, which may be a clue as to how much compulsive eating is accounted for by behavioral addiction.
Weight-Loss Drugs — Bait and Switch?
People have all kinds of reasons to pursue weight loss, but then they might discover they have been sold a life-long chemical dependency.
Weight-Loss Drugs, Exercise, and General Functionality
While taking obesity management drugs it is essential to maintain a high level of exercise to not only lose fat but build muscle mass.
Weight-Loss Drugs and Exercise
Weight-loss drugs are intended to be used along with deliberate diet modification and perpetual exercise, but not everyone wants to hear it.
Weight-Loss Drugs, Safety, and the Brain
People might tend to think that if the FDA approves something, then it must be okay. As an antidote to that delusion consider this.
Weight-Loss Drugs and Pregnancy
The semaglutide drugs Ozempic and Wegovy, intended to treat Type 2 diabetes and obesity, respectively, are a risky bet for pregnant people.
Are the Weight-loss Drugs Worth It?
Under optimal conditions and with mindful compliance, what can be expected from weight-loss drugs?
GLP-1 Agonist Drugs Show Promise for Treating More Conditions
GLP-1 agonist drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are showing promise for treating various conditions beyond their original scope.
GLP-1 Weight Loss Drugs in the News, Again
Let’s take a look at the latest headlines to glimpse at what’s happening in the world of weight loss meds.